0001209191-15-080389.txt : 20151116
0001209191-15-080389.hdr.sgml : 20151116
20151116182106
ACCESSION NUMBER: 0001209191-15-080389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151116
FILED AS OF DATE: 20151116
DATE AS OF CHANGE: 20151116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lo Steven
CENTRAL INDEX KEY: 0001501959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 151236630
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-11-16
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001501959
Lo Steven
C/O CORCEPT THERAPEUTICS
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
0
1
0
0
SVP Oncology
Common stock
2015-11-16
4
M
0
113960
3.51
A
113960
D
Common stock
2015-11-16
4
M
0
286040
3.51
A
400000
D
Common stock
2015-11-16
4
M
0
33333
2.70
A
433333
D
Common stock
2015-11-16
4
M
0
64583
2.075
A
497916
D
Common stock
2015-11-16
4
M
0
87500
1.92
A
585416
D
Stock option
3.51
2015-11-16
4
M
0
113960
3.51
A
2020-09-23
Common stock
113960
0
D
Stock option
3.51
2015-11-16
4
M
0
286040
3.51
A
2020-09-23
Common stock
286040
0
D
Stock option
2.70
2015-11-16
4
M
0
33333
2.70
A
2022-10-09
Common stock
33333
0
D
Stock option
2.075
2015-11-16
4
M
0
64583
2.075
A
2023-01-29
Common stock
64583
0
D
Stock option
1.92
2015-11-16
4
M
0
87500
1.92
A
2023-11-18
Common stock
87500
0
D
Exercise and hold.
Fully exerciseable.
/s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact
2015-11-16